Status:
COMPLETED
Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
Lead Sponsor:
Novartis
Conditions:
Hypertension
Impaired Glucose Tolerance
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
THE PURPOSE OF THIS STUDY IS TO DETERMINE IF 24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG) IMPROVES INSULIN SENSITIVITY IN SUBJECTS WITH HIGHER THAN NORMAL GLUCOSE LEVELS USING A TEST CALLED T...
Eligibility Criteria
Inclusion
- history or presenting hypertension Elevated fasting blood glucose levels -
Exclusion
- Pregnancy potential Diabetes mellitus
- Other criteria apply
- \-
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00241072
Start Date
September 1 2002
End Date
July 1 2005
Last Update
May 4 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.